ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025
Enhanced nnU-Net Architectures for Automated MRI Segmentation of Head and Neck Tumors in Adaptive Radiation Therapy.
Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The increasing utilization of MRI in radiation therapy planning for head and neck cancer (HNC) highlights the need for precise tumor segmentation to enhance treatment efficacy and reduce side effects. This work presents segmentation models developed for the HNTS-MRG 2024 challenge by the team mic-dkfz, focusing on automated segmentation of HNC tumors from MRI images at two radiotherapy (RT) stages: before (pre-RT) and 2-4 weeks into RT (mid-RT). For Task 1 (pre-RT segmentation), we built upon the nnU-Net framework, enhancing it with the larger Residual Encoder architecture. We incorporated extensive data augmentation and applied transfer learning by pre-training the model on a diverse set of public 3D medical imaging datasets. For Task 2 (mid-RT segmentation), we adopted a longitudinal approach by integrating registered pre-RT images and their segmentations as additional inputs into the nnU-Net framework. On the test set, our models achieved mean aggregated Dice Similarity Coefficient (aggDSC) scores of 81.2 for Task 1 and 72.7 for Task 2. Especially the primary tumor (GTVp) segmentation is challenging and presents potential for further optimization. These results demonstrate the effectiveness of combining advanced architectures, transfer learning, and longitudinal data integration for automated tumor segmentation in MRI-guided adaptive radiation therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.